Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-28 · accession 0001209191-24-000175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-02 | 2023-12-28 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.58 | -8,000 | 414.5K | -2% | -$84.6K |
| D | 2024-01-02 | 2023-12-28 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 422.5K | +2% | +$8,480 |
| D | 2024-01-02 | 2023-12-28 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $0.00 | -8,000 | 512.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-28 | S | D | 8,000 | $10.58 | 414,548 | D | — | — | (F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.34 to $10.75 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 2 | Common | Class A Common Stock | 2023-12-28 | M | A | 8,000 | $1.06 | 422,548 | D | — | — | (F2) Includes 1,144 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2023. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-12-28 | M | D | 8,000 | $0.00 | 512,000 | D | $1.06 · — to 2028-07-22 | 8,000 Class A Common Stock | (F5) Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date. |